Page last updated: 2024-10-21

5-hydroxydecanoate and Ventricular Fibrillation

5-hydroxydecanoate has been researched along with Ventricular Fibrillation in 14 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research Excerpts

ExcerptRelevanceReference
"We investigated the effects of sodium 5-hydroxydecanoate (5-HD) on experimentally induced ischemic arrhythmia and its mechanisms of action by biochemical and electrophysiological techniques."7.67[Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia]. ( Dabasaki, T; Funato, H; Ishikawa, H; Kayamoto, M; Niho, T; Notsu, T; Takahashi, H; Tanaka, I; Yamasaki, F; Yamazaki, M, 1987)
" In this study, we investigated whether TZDs affect onset, spectral characteristics, and mortality of ischemic ventricular fibrillation (VF) and whether such effects are recapitulated by a non-selective K(ATP) blocker (glyburide) or a mitochondrial K(ATP) blocker (5-hydroxydecanoate)."3.78Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs. ( Greyson, CR; Lu, L; Reiter, MJ; Sarraf, M; Schwartz, GG; Ye, S, 2012)
" The purpose of this study was to investigate the roles of loss of oxidative phosphorylation and activation of the mitochondrial ATP-sensitive K+ channel and permeability transition pore in VF development during myocardial ischemia by using mitochondrial uncoupling agents (carbonyl cyanide m-chlorophenylhydrazone and 2,4-dinitrophenol) and channel blockers (5-hydroxydecanoate and cyclosporine A) at concentrations that have been demonstrated to block the intended targets selectively."3.77Mitochondrial uncoupling agents trigger ventricular fibrillation in isolated rat hearts. ( Alderson, JM; Clements-Jewery, H; Hatcher, AS, 2011)
" Here, we have assessed its effects on ischaemia- and reperfusion-induced ventricular arrhythmias in vivo and a possible role for mitochondrial K(ATP) channels in these effects, using the channel inhibitor 5-hydroxydecanoate (5-HD)."3.74Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels. ( Huliák, I; Juhász, L; Kiss, A; Végh, A, 2008)
" This study was designed to determine whether clofilium exhibits antifibrillatory activity in a pinacidil + hypoxia-induced model of ventricular fibrillation (VF) in Langendorff-perfused hearts."3.69Antifibrillatory effects of clofilium in the rabbit isolated heart. ( Chi, L; Friedrichs, GS; Green, AL; Lucchesi, BR, 1994)
"We investigated the effects of sodium 5-hydroxydecanoate (5-HD) on experimentally induced ischemic arrhythmia and its mechanisms of action by biochemical and electrophysiological techniques."3.67[Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia]. ( Dabasaki, T; Funato, H; Ishikawa, H; Kayamoto, M; Niho, T; Notsu, T; Takahashi, H; Tanaka, I; Yamasaki, F; Yamazaki, M, 1987)
"Arrhythmias were assessed based on the Lambeth convention and were categorized as number, duration and incidence of ventricular tachycardia (VT), ventricular fibrillation (VF), and premature ventricular complexes (PVC), and arrhythmic score."1.40Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel. ( Badalzadeh, R; Ebrahimi, H; Majidinia, M; Yousefi, B, 2014)
"The duration of ventricular tachycardia (VT) + VF, the number of VT + VF episodes and the severity of arrhythmias were all significantly reduced by Ex-4 compared to those in myocardial ischemia group (p < 0."1.39Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats. ( Daoqun, J; Jie, G; Kai, Z; Lin, Z; Yongbo, W; Zhiqiang, C, 2013)
"Control animals had an average arrhythmia score of 10."1.31Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. ( Fryer, RM; Gross, GJ; Hsu, AK; Nagase, H, 2000)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's3 (21.43)18.2507
2000's6 (42.86)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kai, Z1
Yongbo, W1
Lin, Z1
Jie, G1
Daoqun, J1
Zhiqiang, C1
Badalzadeh, R1
Yousefi, B1
Majidinia, M1
Ebrahimi, H1
Kiss, A1
Juhász, L1
Huliák, I1
Végh, A1
Hatcher, AS1
Alderson, JM1
Clements-Jewery, H1
Sarraf, M1
Lu, L1
Ye, S1
Reiter, MJ1
Greyson, CR1
Schwartz, GG1
Iliodromitis, EK1
Cokkinos, P1
Zoga, A1
Steliou, I1
Vrettou, AR1
Kremastinos, DT1
Maslov, LN1
Lishmanov, YB1
Solenkova, NV1
Gross, GJ2
Stefano, GB1
Tam, SW1
Xu, D1
Li, Y1
Wang, J1
Davey, AK1
Zhang, S1
Evans, AM1
Vajda, S1
Baczkó, I1
Leprán, I1
Friedrichs, GS2
Chi, L2
Green, AL1
Lucchesi, BR2
Abreu, JN1
Black, SC1
Wolk, R1
Cobbe, SM1
Kane, KA1
Hicks, MN1
Fryer, RM1
Hsu, AK1
Nagase, H1
Niho, T1
Notsu, T1
Ishikawa, H1
Funato, H1
Yamazaki, M1
Takahashi, H1
Tanaka, I1
Kayamoto, M1
Dabasaki, T1
Yamasaki, F1

Other Studies

14 other studies available for 5-hydroxydecanoate and Ventricular Fibrillation

ArticleYear
Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats.
    Cardiology journal, 2013, Volume: 20, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Decanoic Acids; Disease Models, Animal; Exenatide;

2013
Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel.
    The journal of physiological sciences : JPS, 2014, Volume: 64, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Decanoic Acids; Diosgenin

2014
Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels.
    British journal of pharmacology, 2008, Volume: 155, Issue:7

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Decanoic Acids; Dogs; Femal

2008
Mitochondrial uncoupling agents trigger ventricular fibrillation in isolated rat hearts.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:4

    Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cyclo

2011
Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs.
    Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Coronary Vessels; Death, Sudden, Cardiac; Decanoic Acids; Female; G

2012
Oral nicorandil recaptures the waned protection from preconditioning in vivo.
    British journal of pharmacology, 2003, Volume: 138, Issue:6

    Topics: Administration, Oral; Animals; Blood Pressure; Decanoic Acids; Disease Models, Animal; Drug Combinat

2003
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels.
    Life sciences, 2003, Jul-04, Volume: 73, Issue:7

    Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Decanoic Acids; Disease Models, Animal; Drug An

2003
The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury.
    Life sciences, 2007, Jan-02, Volume: 80, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Diterpe

2007
Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
    European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3

    Topics: Acute Disease; Anesthesia; Animals; Anti-Arrhythmia Agents; Autonomic Nervous System; Blood Pressure

2007
Antifibrillatory effects of clofilium in the rabbit isolated heart.
    British journal of pharmacology, 1994, Volume: 113, Issue:1

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Disease Models, Animal; Glyburid

1994
5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.
    European journal of pharmacology, 1996, Jun-13, Volume: 306, Issue:1-3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Blood Pressure; Death, Sudden, Cardiac; Decanoic

1996
Relevance of inter- and intraventricular electrical dispersion to arrhythmogenesis in normal and ischaemic rabbit myocardium: a study with cromakalim, 5-hydroxydecanoate and glibenclamide.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Cromakal

1999
Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:2

    Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; B

2000
[Study of mechanism and effect of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1987, Volume: 89, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Decanoic Acids; Dogs; Energ

1987